Holdings of Tema Heart & Health ETF
Tema ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 55.3M $ including 54.9M $ in equities, 99.3 %
- Positions
- 43 in 6 countries
- Top ten
- 47.7 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 5,263 | 5.5M $ | 10.01 % |
| 2 | Roche Holding AG | 50,740 | 3M $ | 5.46 % |
| 3 | Johnson & Johnson | 10,810 | 2.7M $ | 4.85 % |
| 4 | AstraZeneca PLC | 12,706 | 2.7M $ | 4.81 % |
| 5 | Merck & Co Inc | 18,918 | 2.3M $ | 4.23 % |
| 6 | Thermo Fisher Scientific Inc | 4,137 | 2.2M $ | 3.90 % |
| 7 | UnitedHealth Group Inc | 7,253 | 2.1M $ | 3.85 % |
| 8 | Gilead Sciences Inc | 13,435 | 2M $ | 3.62 % |
| 9 | Novartis AG | 11,781 | 2M $ | 3.61 % |
| 10 | Abbott Laboratories | 16,017 | 1.9M $ | 3.37 % |
| 11 | Vertex Pharmaceuticals Inc | 3,568 | 1.8M $ | 3.20 % |
| 12 | AbbVie Inc | 7,045 | 1.6M $ | 2.96 % |
| 13 | Danaher Corp | 7,657 | 1.6M $ | 2.92 % |
| 14 | Boston Scientific Corp | 17,749 | 1.4M $ | 2.47 % |
| 15 | Medtronic PLC | 13,377 | 1.3M $ | 2.36 % |
| 16 | Bridgebio Pharma Inc | 18,567 | 1.2M $ | 2.23 % |
| 17 | Revolution Medicines Inc | 11,995 | 1.2M $ | 2.21 % |
| 18 | Bristol-Myers Squibb Co | 19,189 | 1.2M $ | 2.16 % |
| 19 | McKesson Corp | 1,210 | 1.2M $ | 2.16 % |
| 20 | Novo Nordisk A/S | 31,589 | 1.2M $ | 2.15 % |
| 21 | Amgen Inc | 2,984 | 1.2M $ | 2.09 % |
| 22 | Chugai Pharmaceutical Co Ltd | 16,971 | 1.1M $ | 2.05 % |
| 23 | Regeneron Pharmaceuticals, Inc. | 1,426 | 1.1M $ | 2.02 % |
| 24 | Edwards Lifesciences Corp | 11,887 | 1M $ | 1.86 % |
| 25 | Teva Pharmaceutical Industries Ltd | 26,392 | 893.6K $ | 1.62 % |
| 26 | Cytokinetics Inc | 13,108 | 815.6K $ | 1.47 % |
| 27 | Intuitive Surgical Inc | 1,610 | 810.7K $ | 1.47 % |
| 28 | Masimo Corp | 4,286 | 751.6K $ | 1.36 % |
| 29 | Dexcom Inc | 9,698 | 712.1K $ | 1.29 % |
| 30 | Madrigal Pharmaceuticals Inc | 1,551 | 670K $ | 1.21 % |
| 31 | Insmed Inc | 4,417 | 659.6K $ | 1.19 % |
| 32 | Alnylam Pharmaceuticals Inc | 1,972 | 656.5K $ | 1.19 % |
| 33 | Insulet Corp | 2,336 | 576.1K $ | 1.04 % |
| 34 | Arrowhead Pharmaceuticals Inc | 8,970 | 567.5K $ | 1.03 % |
| 35 | Viking Therapeutics Inc | 13,867 | 469.3K $ | 0.85 % |
| 36 | Ionis Pharmaceuticals Inc | 5,673 | 460.4K $ | 0.83 % |
| 37 | Scholar Rock Holding Corp | 9,773 | 432.7K $ | 0.78 % |
| 38 | Ascendis Pharma A/S | 1,777 | 414.9K $ | 0.75 % |
| 39 | Crinetics Pharmaceuticals Inc | 8,655 | 355.7K $ | 0.64 % |
| 40 | Neurocrine Biosciences Inc | 2,387 | 315.7K $ | 0.57 % |
| 41 | Zealand Pharma A/S | 5,363 | 308.5K $ | 0.56 % |
| 42 | Gubra A/S | 4,545 | 281K $ | 0.51 % |
| 43 | Intellia Therapeutics Inc | 14,076 | 194K $ | 0.35 % |
Sector breakdown
- Health care 80.6 %
- Unattributed 19.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 86.2 %
- GBP 4.8 %
- CHF 3.6 %
- DKK 3.2 %
- JPY 2.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 78.3 %
- Switzerland 9.1 %
- United Kingdom 4.8 %
- Denmark 4.0 %
- Japan 2.1 %
- Israel 1.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 34 | 43M $ | 78.32 % |
| 2 | Switzerland | 2 | 5M $ | 9.15 % |
| 3 | United Kingdom | 1 | 2.7M $ | 4.85 % |
| 4 | Denmark | 4 | 2.2M $ | 3.99 % |
| 5 | Japan | 1 | 1.1M $ | 2.07 % |
| 6 | Israel | 1 | 893.6K $ | 1.63 % |
Cite this page
Titelia. "Holdings of Tema Heart & Health ETF". https://titelia.com/en/funds/S000081541